Cargando…
Trial Design for Cancer Immunotherapy: A Methodological Toolkit
SIMPLE SUMMARY: Immunotherapy has become a very important treatment against several types of cancer. The clinical trials of immunotherapy have shown that these treatments present us with some novel challenges in terms of the methodology required to assess their efficacy and safety. In this article,...
Autores principales: | Saad, Everardo D., Coart, Elisabeth, Deltuvaite-Thomas, Vaiva, Garcia-Barrado, Leandro, Burzykowski, Tomasz, Buyse, Marc |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10527464/ https://www.ncbi.nlm.nih.gov/pubmed/37760636 http://dx.doi.org/10.3390/cancers15184669 |
Ejemplares similares
-
The case against censoring of progression-free survival in cancer clinical trials – A pandemic shutdown as an illustration
por: Jamoul, Corinne, et al.
Publicado: (2022) -
Surrogacy Beyond Prognosis: The Importance of “Trial-Level” Surrogacy
por: Buyse, Marc, et al.
Publicado: (2022) -
Statistical Considerations for Trials in Adjuvant Treatment of Colorectal Cancer
por: Saad, Everardo Delforge, et al.
Publicado: (2020) -
The evaluation of surrogate endpoints
por: Burzykowski, Tomasz, et al.
Publicado: (2005) -
Generalized pairwise comparisons of prioritized outcomes are a powerful and patient-centric analysis of multi-domain scores
por: Deltuvaite-Thomas, Vaiva, et al.
Publicado: (2023)